Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 • 2,115 citations

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

1997 • 1,783 citations

Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902

2001 • 1,091 citations

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

2002 • 711 citations

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

1998 • 581 citations

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1988 • 511 citations

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

1994 • 435 citations

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up

1999 • 433 citations

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.

1995 • 422 citations

Incidence and Impact of Documented Eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated With Neoadjuvant Chemotherapy

1999 • 351 citations

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

1995 • 348 citations

Pathological assessment of response to induction chemotherapy in breast cancer.

1986 • 337 citations

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1994 • 208 citations

Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?

1998 • 191 citations

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.

1995 • 186 citations

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.

1997 • 174 citations

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1995 • 158 citations

Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy

1989 • 156 citations

Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery

2001 • 153 citations

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

1998 • 142 citations

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

2000 • 128 citations

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.

1995 • 126 citations

Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1999 • 124 citations

Maximized Reduction of Primary Breast Tumor Size Using Preoperative Chemotherapy With Doxorubicin and Docetaxel

1999 • 124 citations

Effects of Chemotherapy on Pathologic and Biologic Characteristics of Locally Advanced Breast Cancer

1997 • 123 citations

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.

1998 • 117 citations

Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer.

1995 • 108 citations

Primary chemotherapy in operable breast cancer.

1996 • 80 citations

Preoperative (neoadjuvant) chemotherapy in patients with breast cancer

2001 • 78 citations

Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy

1997 • 74 citations

Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues

2000 • 62 citations

Primary chemotherapy for early and advanced breast cancer

1995 • 41 citations

Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.

2001 • 41 citations

The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.

1999 • 36 citations

Improvements in survival in patients receiving primary chemotherapy with docetaxel for breast cancer: A randomised controlled trial

2001 • 21 citations

A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer

2001 • 15 citations

PRIMARY CHEMOTHERAPY FOR OPERABLE BREAST CANCER.

1998 • 6 citations

[Tumor regression as a prognostic factor in breast cancer].

1991 • 2 citations